1. Home
  2. Medical News
  3. Cataract/Refractive Surgery

Hoya Presents New Clinical Evidence on Myopia Management and Launch of visuReal MoveAI Kids Module

05/19/2025

Hoya Vision Care presented its latest clinical evidence at the 16th Annual European Academy of Optometry and Optics (EAOO) conference in Ljubljana, Slovenia. The company also unveiled its new visuReal MoveAI Kids Module, an AI-powered video centration system for fitting children's eyewear.

HOYA shared several updates from ongoing research in myopia management, including 8-year results from the longest-running clinical study on myopia management spectacle lenses. According to Hoya, these latest findings demonstrate that wearing MiYOSMART spectacle lenses continuously and for the long-term provides an effective, safe, noninvasive myopia control strategy in children, with maximum benefits achieved through continuous wear. 

A 2-year observational study of 103 European children aged 5–15 years[2] indicated that DIMS spectacle lenses are similarly effective in slowing myopia progression in both UK and Hong Kong pediatric populations when comparing the results with existing data[4]. In UK children wearing DIMS spectacle lenses, there was an average change in axial length growth of 0.17±0.19mm and 0.12±0.13mm after 1 and 2 years of wear, respectively. 

A separate study concluded that myopia progression could be variable depending on the types of astigmatism in children wearing DIMS spectacle lenses. The study of 184 children (79 Asian and 105 European) found that astigmatic myopic patients had higher myopia, but patients in the spherical group experienced faster myopic progression.[3]  

“The evidence for long-term continuous DIMS spectacle lens wear and the 2-year observational study in a European population demonstrate MiYOSMART’s effectiveness in slowing myopia progression," Natalia Vlasak, MD, Global Head of Medical and Scientific Affairs at Hoya Vision Care. "Combined with our insights into how different astigmatism types can influence myopia management outcomes, this research highlights Hoya Vision Care’s leadership in advancing the understanding of myopia, our continuous innovation in delivering effective solutions globally, and our commitment to paving the way for tailored treatments in children’s eye health worldwide."  

Hoya unveiled their 'visuReal MoveAI Kids' module at EAOO 2025, marking the global debut of its video centration module specifically designed for children. The company says visuReal MoveAI is a flexible, accurate, and user-friendly portable digital centration solution. With its integrated application, intuitive interface and AI-powered automated detection, visuReal MoveAI is designed to make lens centration fast and easy.[5] 

References 

  1. Leung TW, et al. Comparison of Myopia Progression in Individuals Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses for Eight Years versus Shorter Durations. Poster number A0113. Presented 6th May at ARVO 2025. 
  2. Saunders KJ, et al. Multi-Site Observational Study of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in UK children: 2-year results. Presented 18th May at EAOO 2025.    
  3. Hoogendoorn J, et al. Influence of Different Types of Astigmatism on Myopia Progression in Children Wearing Defocus Incorporated Multiple Segments Spectacles. Presented 17th May at EAOO 2025. 
  4. Lam CSY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. Br J Ophthalmol. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739/. 
  5. HOYA Vision Care. visuReal Moveᴬᴵ. Available at https://www.hoyavision.com/uk/your-business-partner/deliver-the-best-patient-care/hoya-visureal-move%E1%B4%AC%E1%B4%B5/ Accessed: May 2025. 

Register

We're glad to see you're enjoying Modern Optometry…
but how about a more personalized experience?

Register for free